← All trials
NCT02627378
Phase 1Interventional
Includes initial studies to determine the metabolism and pharmacologic actions of drugs in humans, the side effects associated with increasing doses, and to gain early evidence of effectiveness; may include healthy participants and/or patients.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Sep 30, 2012
- Primary completion
- Jun 30, 2015
- Completion date
- Oct 31, 2015
- First posted
- Dec 10, 2015
- Last posted
- Dec 10, 2015
- Enrollment
- 35
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Imam Abdulrahman Bin Faisal UniversityLead sponsor
- King Abdul-Aziz UniversityCollaborator
- King Abdul-Aziz UniversityOverall official - principal investigator
- Government of Saudi ArabiaCollaborator
- Imam Abdulrahman Bin Faisal UniversityOfficial
- King Abdul-Aziz UniversityOfficial
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.